Stocks and Investing
Stocks and Investing
Tue, November 19, 2013
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, November 18, 2013
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, November 15, 2013
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, November 14, 2013
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, November 13, 2013
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, November 12, 2013
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Yun Zhong Downgraded (SRPT) to Strong Sell and Decreased Target to $10 on, Nov 12th, 2013
Yun Zhong of Janney Montgomery Scott, Downgraded "Sarepta Therapeutics, Inc." (SRPT) to Strong Sell and Decreased Target from $34 to $10 on, Nov 12th, 2013.
Yun has made no other calls on SRPT in the last 4 months.
There is 1 other peer that has a rating on SRPT. Out of the 1 peers that are also analyzing SRPT, all agrees with Yun's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Joel Beatty of "Citigroup" Initiated at Hold on, Tuesday, August 27th, 2013